Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of Zhengyuan Capsule for chemotherapy-related cancer fatigue
CTR20220743Phase 2Active
- Sponsor
- Guangzhou Hairui Pharmaceutical
- Start
- Apr 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Zhengyuan Capsule in cancer-related fatigue (CRF), sponsored by Guangzhou Hairui Pharmaceutical. Started Apr 2022; status: active.
02
Drugs
Zhengyuan Capsule
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on CTR20220743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220743.